IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer


Investigators

Thomas A Mace
Reena Shakya
Jason R Pitarresi
Benjamin Swanson
Christopher W McQuinn
Shannon Loftus
Emily Nordquist
Zobeida Cruz-Monserrate
Lianbo Yu
Gregory Young
Xiaoling Zhong
Teresa A Zimmers
Michael C Ostrowski
Thomas Ludwig
Mark Bloomston
Tanios Bekaii-Saab
Gregory B Lesinski

Filters: 2018